Clin Diabetes. 2025 Jan 6;43(2):282-290. doi: 10.2337/cd24-0082. eCollection 2025 Spring.
ABSTRACT
Diabetes affects approximately 6% of the population, with 20% developing foot ulcers. Gout affects about 3% of the population, but <40% receive sufficient urate-lowering therapy to prevent or dissolve urate crystal (tophi) deposition in the feet, which can ulcerate and become infected. Among patients with diabetes, 20% also have gout. This study aimed to assess adherence to recommended gout treatment in patients with diabetes and to compare usual care with initial care provided by a nurse-led gout care program. In patients with diabetes, gout is frequently undertreated, particularly when not initially managed in a nurse-led gout care program.
PMID:40290813 | PMC:PMC12019000 | DOI:10.2337/cd24-0082